Intestinal Barrier Healing for Predicting Major Adverse Outcomes in IBD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in IBD: the prospective ERIca trial
Gastroenterology 2022 Oct 21;[EPub Ahead of Print], T Rath, R Atreya, J Bodenschatz, W Uter, CE Geppert, F Vitali, S Fischer, MJ Waldner, JF Colombel, A Hartmann, MF NeurathFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.